For most adults with uncomplicated obstructive sleep apnea (OSA), CPAP and APAP are the usual choices. CPAP holds one prescribed treatment pressure. APAP adjusts pressure within a prescribed range as breathing changes. Bilevel positive airway pressure uses a higher pressure while you breathe in and a lower pressure while you breathe out.
Bilevel is not automatically stronger, better, or reserved for severe OSA. It may be tried when fixed or auto-adjusting PAP is difficult to tolerate at the pressure needed, and it is also used in specific breathing disorders. In those disorders, the exact mode and monitoring matter as much as the word “bilevel.”
“BiPAP” is a Philips trademark used for its bilevel products. Bilevel PAP or BPAP is the generic term, so a bilevel machine from another manufacturer is not technically a BiPAP 1.
CPAP, APAP, and bilevel at a glance
| Therapy | How pressure behaves | Common role | Main qualification |
|---|---|---|---|
| Fixed CPAP | Holds one prescribed treatment pressure through the breathing cycle | Ongoing treatment for uncomplicated OSA | Some devices add brief exhalation relief, but that comfort feature is not the same as prescribed bilevel therapy |
| APAP | Moves within a clinician-set minimum and maximum range using a manufacturer-specific algorithm | Starting or continuing treatment for uncomplicated OSA | It still needs a suitable diagnosis, a sensible prescribed range, and follow-up data |
| Bilevel PAP or BPAP | Uses a higher inspiratory pressure, called IPAP, and a lower expiratory pressure, called EPAP | Selected OSA cases and mode-specific ventilatory support | Ordinary spontaneous bilevel, bilevel with a backup rate, ASV, and volume-assured support are not interchangeable |
FDA consumer information likewise describes CPAP as continuous pressure and bilevel PAP as higher pressure during inhalation and lower pressure during exhalation 2.
How each pressure pattern works
Fixed CPAP
CPAP provides one fixed pressure to hold the upper airway open. A clinician may identify that pressure during an overnight titration or from a monitored APAP trial. Ramp and branded exhalation-relief features can temporarily soften how treatment feels, but the device is still operating as CPAP rather than providing independently prescribed IPAP and EPAP.
A fixed setting can be useful when one pressure controls obstruction reliably. It also removes pressure variation as a possible source of discomfort. Fixed does not mean unresponsive care: the mask, leak, symptoms, and device data still need follow-up.
APAP
APAP detects airflow or related signals and changes pressure within the prescribed range according to its own algorithm. The goal is to use enough pressure to keep the airway open as needs vary with sleep stage, body position, nasal congestion, or other factors. Algorithms differ between manufacturers, so two APAP models may not respond in exactly the same way 3.
APAP does not independently diagnose every breathing problem or decide its own unrestricted pressure. The clinician sets its operating range and reviews the response. A range that is too broad or poorly matched to the person can leave problems unresolved even when the machine says it is in auto mode.
Bilevel PAP
Bilevel PAP switches between IPAP and EPAP. EPAP can help keep the upper airway from collapsing. The difference between IPAP and EPAP, called pressure support, can make exhalation feel easier and can assist ventilation in an appropriate mode.
That last distinction matters. A basic spontaneous bilevel mode follows the user's own breaths. A spontaneous-timed mode adds a backup rate if spontaneous breathing becomes too slow or pauses. Adaptive servo-ventilation (ASV) changes pressure support dynamically to stabilize certain central breathing patterns. Volume-assured modes adjust support toward a ventilation target 1. A home ventilator may offer some of these patterns, but its prescribed role and safety features depend on the exact product.
These labels can overlap across products, but they do not make the devices clinically interchangeable. The prescription must identify the condition, mode, settings, interface, and monitoring needed.
What the evidence says for uncomplicated OSA
AASM guidance recommends either home APAP initiation or an in-laboratory PAP titration for adults with OSA who do not have significant complicating conditions. It recommends either CPAP or APAP for ongoing treatment and suggests CPAP or APAP over bilevel for routine OSA treatment 4.
The supporting systematic review found no clinically meaningful difference between APAP and fixed CPAP in residual OSA severity, average use, daytime sleepiness, or quality of life. Some people prefer the lower pressures APAP may deliver at parts of the night; others prefer the steadiness of fixed CPAP. The evidence does not identify one as universally more effective or more comfortable 3.
Bilevel can feel easier to exhale against, especially when the required treatment pressure is difficult to tolerate. However, trials in routine OSA did not show a clinically meaningful overall advantage over CPAP for residual events, sleepiness, or adherence. Evidence for bilevel as a rescue option after poor CPAP adherence was limited and imprecise 3.
This is why the choice is not:
- mild OSA means CPAP
- moderate OSA means APAP
- severe OSA means bilevel
A person with severe purely obstructive apnea may do well on fixed CPAP. A person with a lower apnea-hypopnea index may need a specialized ventilatory mode because of a separate breathing disorder. The event type, carbon dioxide level, oxygen needs, other diseases, response to titration, and ability to use treatment all influence the decision.
When bilevel is considered
For pressure or comfort problems in OSA
A clinician may consider bilevel when the pressure needed to control obstruction is beyond the useful range of CPAP or APAP equipment, or when exhalation remains intolerable despite careful troubleshooting. Bilevel is not guaranteed to solve discomfort, and a device change should not be the first response to every leak, dry mouth, or poor night.
Before switching modes, review:
- mask size, seal, and movement during sleep
- mouth leak and nasal blockage
- humidification and condensation
- aerophagia, difficulty exhaling, and awakenings
- actual nightly use, residual events, leak, and pressure trends
PAP downloads can report use, estimated residual OSA, leak, and settings, and remote monitoring can support early troubleshooting. These estimates are useful in context, but they do not replace a diagnostic or titration study when the breathing pattern is unclear 3.
For hypoventilation or respiratory muscle weakness
Hypoventilation means the lungs are not moving enough air to clear carbon dioxide. In this setting, the clinical goal is not only to splint an obstructed upper airway. The device may need to support ventilation using an adequate pressure difference, a backup rate, a volume-assured mode, or a home ventilator.
The diagnosis still matters. For stable ambulatory obesity hypoventilation syndrome with severe OSA, an ATS guideline suggests CPAP rather than noninvasive ventilation as the first treatment. Noninvasive ventilation is used in other OHS situations, including an inadequate response to CPAP or some cases without severe OSA 5.
For neuromuscular disease with chronic respiratory failure, a CHEST guideline recommends noninvasive ventilation and emphasizes individualized settings to meet ventilation goals 6. For chronic stable hypercapnic COPD, ATS conditionally suggests nocturnal noninvasive ventilation and recommends screening for coexisting OSA before starting it 7.
These are physiological indications for specialist-managed ventilation. They are not evidence that everyone with COPD, obesity, muscle weakness, or severe OSA should use ordinary bilevel PAP.
For central or treatment-emergent apnea
Central sleep apnea occurs when airflow stops because breathing effort is absent or reduced, rather than because the upper airway simply collapses. Treatment-emergent central apnea appears or persists after PAP is started for predominantly obstructive apnea.
The current AASM central sleep apnea guideline conditionally supports different treatments for different causes, including CPAP, bilevel with a backup rate, and ASV. It suggests against bilevel without a backup rate for central sleep apnea because this mode can worsen central events. If CPAP is tried, response should be confirmed with sleep testing or PAP-generated data rather than assumed 8.
ASV is not ordinary auto bilevel. It uses dynamic support for unstable central breathing. Its use in people with heart failure and reduced ejection fraction requires particular caution, shared decision-making, and monitoring in an experienced sleep center because safety findings have differed between trials and device algorithms 8.
Do not respond to a device-reported “central” event by changing pressure or buying a bilevel machine. Leak, wakefulness, altitude, medicines such as opioids, heart failure, and other medical conditions can affect the pattern and its interpretation.
In acute breathing failure
Hospitals also use CPAP or bilevel noninvasive ventilation for selected forms of acute respiratory failure. That is a separate, monitored medical context. The diagnosis, blood gases, ability to protect the airway, risk of vomiting or aspiration, circulation, and response to treatment affect whether noninvasive support is appropriate or whether invasive ventilation is needed 9.
A home OSA device should not be used to self-treat sudden breathlessness or an acute COPD, heart, or neuromuscular crisis. Seek urgent medical care for severe breathing difficulty, blue or gray lips, confusion, inability to stay awake, chest pain, or rapidly worsening symptoms.
How treatment is started and adjusted
For uncomplicated adult OSA, either of these routes may be reasonable:
- An in-laboratory titration tests pressures while sleep, breathing events, oxygen, leak, and other signals are observed.
- A clinician-prescribed home APAP trial uses a defined range and follow-up data to assess response or select an ongoing setting.
Trials found similar adherence, sleepiness, quality of life, and OSA control with home APAP initiation and laboratory titration in adults without significant comorbidities. Those results do not automatically apply to heart failure, significant lung disease, neuromuscular disease, oxygen requirements, hypoventilation, or central sleep apnea, because these groups were excluded from the evidence base behind the recommendation 4 3.
Bilevel and advanced-mode titration is more condition-specific. Clinicians may need to assess obstruction, ventilation, carbon dioxide, oxygen, synchrony, spontaneous breathing, and whether a backup rate is required. A mode that looks comfortable in a menu may be physiologically wrong for the problem being treated.
Getting comfortable without guessing at the mode
Whichever device is prescribed, effective treatment depends on being able to use it. A well-chosen mask, controlled leak, appropriate humidification, and early troubleshooting can matter more than the letters printed on the machine.
Contact the PAP team if you cannot exhale comfortably, repeatedly remove the mask, swallow air, develop severe dryness or congestion, see persistent high leak or residual events, or remain markedly sleepy despite regular use. Bring the device download and describe what you feel and when it occurs.
Do not change prescribed pressure, APAP range, IPAP, EPAP, pressure support, backup rate, mode, or supplemental oxygen on your own. These settings interact. A change intended to improve comfort can leave obstruction untreated, reduce ventilation, or worsen central breathing instability.
The right device is the mode that safely treats the diagnosed breathing problem, is tolerable enough to use consistently, and produces follow-up data consistent with effective treatment.
